A British company named GW Pharma is seeking FDA approval to sell a marijuana-based prescription painkiller in the U.S.  The drug, which is administered as an oral spray and is intended for cancer patients, is the world’s first prescription drug that contains raw marijuana.  According to API reports, GW Pharma hopes to begin marketing the new drug, which it calls Sativex, in 2013.…